ETF Managers Group’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
$2.08M Sell
10,382
-742
-7% -$149K 0.07% 150
2022
Q4
$2.64M Sell
11,124
-90
-0.8% -$21.4K 0.12% 97
2022
Q3
$2.25M Sell
11,214
-23,965
-68% -$4.8M 0.07% 145
2022
Q2
$5.12M Buy
35,179
+18,279
+108% +$2.66M 0.15% 126
2022
Q1
$2.79M Sell
16,900
-5,379
-24% -$889K 0.06% 177
2021
Q4
$3.81M Sell
22,279
-3,423
-13% -$585K 0.08% 176
2021
Q3
$4.56M Buy
25,702
+6,822
+36% +$1.21M 0.09% 154
2021
Q2
$3.13M Sell
18,880
-7,892
-29% -$1.31M 0.05% 186
2021
Q1
$3.62M Buy
26,772
+7,069
+36% +$955K 0.06% 153
2020
Q4
$2.58M Buy
19,703
+1,380
+8% +$181K 0.06% 174
2020
Q3
$2.66M Buy
18,323
+7,966
+77% +$1.16M 0.08% 142
2020
Q2
$1.53M Buy
10,357
+7,415
+252% +$1.1M 0.05% 152
2020
Q1
$320K Buy
2,942
+300
+11% +$32.6K 0.01% 285
2019
Q4
$303K Buy
2,642
+607
+30% +$69.6K 0.01% 371
2019
Q3
$165K Sell
2,035
-73
-3% -$5.92K 0.01% 495
2019
Q2
$150K Buy
2,108
+906
+75% +$64.5K ﹤0.01% 515
2019
Q1
$112K Buy
1,202
+116
+11% +$10.8K 0.01% 485
2018
Q4
$79K Buy
1,086
+147
+16% +$10.7K ﹤0.01% 520
2018
Q3
$82K Buy
939
+98
+12% +$8.56K ﹤0.01% 531
2018
Q2
$66 Sell
841
-528
-39% -$41 ﹤0.01% 387
2018
Q1
$139K Buy
1,369
+170
+14% +$17.3K 0.01% 241
2017
Q4
$158K Buy
1,199
+170
+17% +$22.4K 0.01% 218
2017
Q3
$121K Buy
1,029
+85
+9% +$10K 0.01% 135
2017
Q2
$75K Buy
+944
New +$75K 0.01% 206
2016
Q1
$23K Buy
+450
New +$23K 0.02% 439